STERIS plc (STE) DCF Valuation

STERIS PLC (STE) VALUATION DCF

IE | Healthcare | Medical - Devices | NYSE
STERIS plc (STE) DCF Valuation

Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets

Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur

Pré-Construits Pour Une Utilisation Rapide Et Efficace

Compatible MAC/PC, entièrement débloqué

Aucune Expertise N'Est Requise; Facile À Suivre

STERIS plc (STE) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Améliorez vos choix d'investissement avec la calculatrice DCF STERIS PLC (STE)! Explorez les données financières authentiques de STERIS, ajustez les projections et les dépenses de croissance et observez comment ces modifications affectent la valeur intrinsèque de Steris Plc (STE) en temps réel.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 3,030.9 3,107.5 4,585.1 4,957.8 5,138.7 5,933.3 6,850.8 7,910.2 9,133.4 10,545.7
Revenue Growth, % 0 2.53 47.55 8.13 3.65 15.46 15.46 15.46 15.46 15.46
EBITDA 743.2 800.3 957.2 1,344.0 1,412.4 1,492.2 1,722.9 1,989.3 2,297.0 2,652.1
EBITDA, % 24.52 25.75 20.88 27.11 27.49 25.15 25.15 25.15 25.15 25.15
Depreciation 197.2 219.2 553.1 552.9 565.2 567.0 654.6 755.9 872.7 1,007.7
Depreciation, % 6.51 7.06 12.06 11.15 11 9.56 9.56 9.56 9.56 9.56
EBIT 545.9 581.1 404.1 791.1 847.2 925.2 1,068.3 1,233.5 1,424.2 1,644.5
EBIT, % 18.01 18.7 8.81 15.96 16.49 15.59 15.59 15.59 15.59 15.59
Total Cash 319.6 220.5 348.3 208.4 207.0 397.2 458.6 529.5 611.4 705.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 586.5 609.4 799.0 865.0 1,008.3
Account Receivables, % 19.35 19.61 17.43 17.45 19.62
Inventories 248.3 315.1 575.0 695.5 674.5 688.6 795.0 918.0 1,059.9 1,223.8
Inventories, % 8.19 10.14 12.54 14.03 13.13 11.61 11.61 11.61 11.61 11.61
Accounts Payable 149.3 157.0 225.7 264.2 251.7 298.2 344.3 397.5 459.0 530.0
Accounts Payable, % 4.93 5.05 4.92 5.33 4.9 5.03 5.03 5.03 5.03 5.03
Capital Expenditure -214.5 -239.3 -287.6 -362.0 -360.3 -419.6 -484.5 -559.4 -645.9 -745.8
Capital Expenditure, % -7.08 -7.7 -6.27 -7.3 -7.01 -7.07 -7.07 -7.07 -7.07 -7.07
Tax Rate, % 46.18 46.18 46.18 46.18 46.18 46.18 46.18 46.18 46.18 46.18
EBITAT 446.3 446.2 313.4 538.1 455.9 662.3 764.7 883.0 1,019.5 1,177.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -256.4 344.1 198.1 581.0 526.0 741.4 703.0 811.7 937.2 1,082.1
WACC, % 7.64 7.61 7.62 7.56 7.48 7.58 7.58 7.58 7.58 7.58
PV UFCF
SUM PV UFCF 3,398.9
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 1,125
Terminal Value 31,413
Present Terminal Value 21,797
Enterprise Value 25,196
Net Debt 3,176
Equity Value 22,020
Diluted Shares Outstanding, MM 99
Equity Value Per Share 221.62

What You Will Receive

  • Pre-Filled Financial Model: STERIS plc's actual data allows for accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth rates, profit margins, WACC, and other critical factors.
  • Real-Time Calculations: Automatic updates provide immediate feedback as you adjust parameters.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, facilitating repeated use for in-depth forecasts.

Key Features

  • Comprehensive STERIS Financials: Gain access to precise pre-loaded historical data and future forecasts.
  • Adjustable Forecast Parameters: Modify highlighted cells for WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Clear charts and summaries to help visualize your valuation findings.
  • Suitable for All Skill Levels: An intuitive design tailored for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file for STERIS plc (STE).
  2. Step 2: Review STERIS plc's pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust assumptions.
  5. Step 5: Analyze the outputs and leverage the results for investment decisions.

Why Choose This Calculator for STERIS plc (STE)?

  • Comprehensive Tool: Incorporates DCF, WACC, and financial ratio analyses all in one convenient package.
  • Customizable Inputs: Modify the highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically computes STERIS plc’s intrinsic value and Net Present Value.
  • Preloaded Data: Access historical and projected data for accurate analysis.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focused on STERIS plc (STE).

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling STERIS plc (STE) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for STERIS plc (STE).
  • Consultants: Deliver professional valuation insights on STERIS plc (STE) to clients quickly and accurately.
  • Business Owners: Understand how large companies like STERIS plc (STE) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to STERIS plc (STE).

What the Template Contains

  • Preloaded STE Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.